We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Removal of the Evolution® Esophageal Stent - Fully Covered
Updated: 12/31/1969
Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
STP206 for the Prevention of NEC
Updated: 12/31/1969
A Phase Ib Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Updated: 12/31/1969
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus in Preterm infants-a Multicenter Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Updated: 12/31/1969
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Updated: 12/31/1969
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials